Clinical Trial Update: Nivolumab and HPV-16 Vaccination in Patients With HPV-16 Positive Incurable Solid Tumors [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating nivolumab in combination with an HPV-16 vaccination for HPV-16 positive incurable solid tumors; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• HPV-16 Vaccination
• nivolumab (nivolumab)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Solid Tumors | Phase 2 | Status: COMPLETED | Results posted: 2023-04-18